Hypervascular Tumors clinical trials at University of California Health

2 in progress, 1 open to eligible people

Showing trials for

  • Instylla HES Hypervascular Tumor Pivotal Study

    open to eligible people ages 22 years and up

    To determine whether Instylla HES has the ability to effectively embolize targeted arterial segments of hypervascular tumors as well as (i.e., is non-inferior to) standard of care (SOC) transarterial embolization/conventional transarterial chemoembolization, while resulting in an acceptable risk of device and procedure-related serious adverse events.

    at UC Irvine UCLA

  • An Observational Study of Radial Access Embolization Procedures Using HydroPearl Microspheres

    Sorry, in progress, not accepting new patients

    This registry study is designed to collect data on the procedural success and complication rates in real-world patients undergoing HydroPearl embolization procedures via radial access.

    at UCLA

Last updated: